购买
下载掌阅APP,畅读海量书库
立即打开
畅读海量书库
扫码下载掌阅APP

参考文献

[1]FURMAN S,ROBINSON G. The use of an intracardiac pacemaker in the correction of total heart block. Surg Forum,1958,9:245-248.

[2]FURMAN S,PARKER B,ESCHER DJ. Decreasing electrode size and increasing efficiency of cardiac stimulation. J Surg Res,1971,11(3):105-110.

[3]GREATBATCH W,LEE JH,MATHIAS W,et al. The solid-state lithium battery:a new improved chemical power source for implantable cardiac pacemakers. IEEE Trans Biomed Eng,1971,18(5):317-323.

[4]SLOTWINER D,VARMA N,AKAR JG,et al. HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. Heart Rhythm,2015,12(7):e69-100.

[5]MABO P,VICTOR F,BAZIN P,et al. A randomized trial of long-term remote monitoring of pacemaker recipients(the COMPAS trial).Eur Heart J,2012,33(9):1105-1111.

[6]VARMA N,EPSTEIN AE,IRIMPEN A,et al. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up:the Lumos-T Safely Reduces Routine Office Device Follow-up(TRUST)trial. Circulation,2010,122(4):325-332.

[7]CROSSLEY GH,BOYLE A,VITENSE H,et al. The CONNECT(Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision)trial:the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol,2011,57(10):1181-1189.

[8]GUéDON-MOREAU L,LACROIX D,SADOUL N,et al. A randomized study of remote follow-up of implantable cardioverter defibrillators:safety and efficacy report of the ECOST trial. Eur Heart J,2013,34(8):605-614.

[9]GUéDON-MOREAU L,LACROIX D,SADOUL N,et al. Costs of remote monitoring vs. ambulatory follow-ups of implanted cardioverter defibrillators in the randomized ECOST study. Europace,2014,16(8):1181-1188.

[10]HINDRICKS G,TABORSKY M,GLIKSON M,et al. Implant-based multiparameter telemonitoring of patients with heart failure(IN-TIME):a randomised controlled trial. Lancet,2014,384(9943):583-590.

[11]LANDOLINA M,PEREGO GB,LUNATI M,et al. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators:the evolution of management strategies of heart failure patients with implantable defibrillators(EVOLVO)study. Circulation,2012,125(24):2985-2992.

[12]刘文亨,陈柯萍,宿燕岗,等.远程监测系统在国内心血管植入型电子器械患者中的应用评价.中华心律失常学杂志,2016,20(6):481-485.

[13]张炜,党爱民,樊晓寒,等.扩张型心肌病心脏性猝死患者临床特征分析.中华心律失常学杂志,2016,20(3):207-211.

[14]KUSUMOTO FM,SCHOENFELD MH,BARRETT C,et al. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay:a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation,2019,140(8):e382-e482.

[15]CHEN K,LI Y,DAI Y,et al. Comparison of electrocardiogram characteristics and pacing parameters between left bundle branch pacing and right ventricular pacing in patients receiving pacemaker therapy. Europace,2019,21(4):673-680.

[16]BHATT AG,MUSAT DL,MILSTEIN N,et al. The efficacy of His bundle pacing:lessons learned from implementation for the first time at an experienced electrophysiology center. JACC Clin Electrophysiol,2018,4(11):1397-1406.

[17]DESHMUKH P,CASAVANT DA,ROMANYSHYN M,et al. Permanent,direct His-bundle pacing:a novel approach to cardiac pacing in patients with normal His-Purkinje activation. Circulation,2000,101(8):869-877.

[18]REDDY VY,EXNER DV,CANTILLON DJ,et al. Percutaneous implantation of an entirely intracardiac leadless pacemaker. N Engl J Med,2015,373(12):1125-1135.

[19]REYNOLDS DW,RITTER P. A leadless intracardiac transcatheter pacing system. N Engl J Med,2016,374(26):2604-2605. HK6+AJ5tDD0PQr+EsKo+ZelSIjbCWFA8eyuo6f1AyD29g7FrBQ3LFhFOHs1/gD4z

点击中间区域
呼出菜单
上一章
目录
下一章
×